Overview

Efficacy and Safety of HIP1601 Capsule

Status:
Completed
Trial end date:
2019-12-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and clinical efficacy of HIP1601 in patients with erosive gastroesphageal reflux disease.
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Esomeprazole